See more : Virax Biolabs Group Limited (VRAX) Income Statement Analysis – Financial Results
Complete financial analysis of Ginza Renoir Co., Ltd. (9853.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ginza Renoir Co., Ltd., a leading company in the Restaurants industry within the Consumer Cyclical sector.
- Voyager Acquisition Corp Unit (VACHU) Income Statement Analysis – Financial Results
- Junhe Pumps Holding Co., Ltd (603617.SS) Income Statement Analysis – Financial Results
- Corero Network Security plc (CNS.L) Income Statement Analysis – Financial Results
- Sumitomo Electric Industries, Ltd. (5802.T) Income Statement Analysis – Financial Results
- Coeur Mining, Inc. (CDE) Income Statement Analysis – Financial Results
Ginza Renoir Co., Ltd. (9853.T)
About Ginza Renoir Co., Ltd.
Ginza Renoir Co., Ltd. engages in the coffee shop business in Japan. It also manufactures, processes, and sells food products; and manages franchise stores. The company operates coffee shops under the Tea room Renoir, Cafe Renoir, Miyama Coffee, Cafe Miyama, and NEW YORKER'S Cafe names. Ginza Renoir Co., Ltd. was founded in 1964 and is headquartered in Tokyo, Japan.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 7.35B | 6.12B | 4.56B | 4.17B | 8.05B |
Cost of Revenue | 1.41B | 990.49M | 612.45M | 512.82M | 916.32M |
Gross Profit | 5.94B | 5.13B | 3.94B | 3.66B | 7.13B |
Gross Profit Ratio | 80.87% | 83.83% | 86.56% | 87.71% | 88.61% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 5.93B | 5.53B | 5.17B | 5.60B | 6.70B |
Other Expenses | 0.00 | 241.95M | 1.17B | 72.04M | -16.00M |
Operating Expenses | 5.93B | 5.55B | 5.18B | 5.62B | 6.71B |
Cost & Expenses | 7.34B | 6.54B | 5.80B | 6.13B | 7.63B |
Interest Income | 1.56M | 1.63M | 3.19M | 4.67M | 4.74M |
Interest Expense | 15.36M | 16.54M | 15.13M | 6.18M | 460.00K |
Depreciation & Amortization | 211.01M | 182.48M | 172.75M | 154.38M | 186.99M |
EBITDA | 155.55M | -78.14M | 598.42M | -2.12B | 467.29M |
EBITDA Ratio | 2.12% | 0.19% | 2.36% | -41.38% | 7.47% |
Operating Income | 15.75M | -414.70M | -1.24B | -1.96B | 414.36M |
Operating Income Ratio | 0.21% | -6.77% | -27.16% | -46.98% | 5.15% |
Total Other Income/Expenses | -86.57M | 117.74M | 1.65B | -346.47M | -134.53M |
Income Before Tax | -70.82M | -296.96M | 410.55M | -2.31B | 279.83M |
Income Before Tax Ratio | -0.96% | -4.85% | 9.01% | -55.28% | 3.48% |
Income Tax Expense | -15.36M | -5.74M | 59.60M | 61.61M | 222.39M |
Net Income | -59.14M | -293.53M | 347.41M | -2.37B | 51.07M |
Net Income Ratio | -0.80% | -4.79% | 7.62% | -56.75% | 0.63% |
EPS | -9.68 | -48.05 | 56.87 | -387.70 | 8.36 |
EPS Diluted | -9.68 | -48.05 | 56.87 | -387.70 | 8.35 |
Weighted Avg Shares Out | 6.11M | 6.11M | 6.11M | 6.11M | 6.11M |
Weighted Avg Shares Out (Dil) | 6.11M | 6.11M | 6.11M | 6.11M | 6.12M |
Source: https://incomestatements.info
Category: Stock Reports